Ragweed Immunotherapy in Adult Asthma
Peter S. Creticos(Johns Hopkins University), John W. Yunginger(Mayo Clinic in Arizona), J. Gadde(Asthma and Allergy Specialists), Jane Khoury(Cincinnati Children's Hospital Medical Center), James T. Li(Mayo Clinic in Arizona), Hal B. Richerson, C. Ralph Buncher(University of Cincinnati), Charles E. Reed(Mayo Clinic in Arizona), William R. Solomon, Philip S. Norman(Johns Hopkins University), N. Franklin Adkinson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul Steinberg(Hennepin County Medical Center), Robert K. Bush(UW Health University Hospital), Richard R. Rosenthal(Inova Fairfax Hospital), William W. Busse(University of Wisconsin–Madison)
Cited by 242
Related Papers
Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
|Journal of Allergy and Clinical Immunology|2006|2.3k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
|Journal of Allergy and Clinical Immunology|2001|1.3k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
|New England Journal of Medicine|2011|870